13F Data
Security · CUSIP 55083R203

LYELL IMMUNOPHARMA INC

COM NEW · institutional ownership from 13F filings
13F holders
65
Shares held
6.8M
Value held
$60.3M
New / sold out
65 / 0
Added / reduced
0 / 0
net +6.8M shares

13F holders by quarter

Q2 2025: 65Q3 2025: 57Q4 2025: 67Q1 2026: 73Q2 2026: 86Q3 2026: 31
Q2 2025Q3 2026

Net shares bought by existing holders

Q2 2025: 6.8MQ3 2025: 3.4MQ4 2025: -261.0KQ1 2026: 1.5MQ2 2026: 7.8KQ3 2026: -31.6K
Q2 2025Q3 2026

Top holders · Q2 2025

ManagerSharesValue% of portfolio
ARCH Venture Management, LLC1,820,634$16.1M5.39%
Foresite Capital Management IV, LLC800,399$7.1M5.72%
Almitas Capital LLC579,997$5.1M1.29%
venBio Partners LLC473,479$4.2M3.65%
VANGUARD GROUP INC442,626$3.9M0.00%
Foresite Capital Management V, LLC406,652$3.6M4.45%
PRICE T ROWE ASSOCIATES INC /MD/306,059$2.7M0.00%
Alphabet Inc.293,256$2.6M0.12%
CITADEL ADVISORS LLC271,283$2.4M0.00%
HSG Holding Ltd152,299$1.3M0.07%
55 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest buyers

ManagerChangeShares changeChange %
ARCH Venture Management, LLCNew+1,820,634–
Foresite Capital Management IV, LLCNew+800,399–
Almitas Capital LLCNew+579,997–
venBio Partners LLCNew+473,479–
VANGUARD GROUP INCNew+442,626–
Foresite Capital Management V, LLCNew+406,652–
PRICE T ROWE ASSOCIATES INC /MD/New+306,059–
Alphabet Inc.New+293,256–
CITADEL ADVISORS LLCNew+271,283–
HSG Holding LtdNew+152,299–
55 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sellers

Nothing to show.